![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 28, 2015 5:27:45 PM
A Nobel Prize winning economist named Kenneth Arrow addressed the question of whether stronger or weaker firms have the greater incentive to innovate. Without getting too wonky, Arrow concluded that a weaker firm has the greater incentive to innovate because successful innovation leads to market entry and market share capture not previously held. However, the stronger firm, having already entered the market and captured share, has less to gain from further innovation because it views the additional expenses as only maintaining what it already possesses or their efforts at innovation have proven less fruitful. Consequently, innovative entrants can overtake established firms, not because established firms are managed poorly or suffer from disproportionate and limiting costs, but because of natural market incentives.
Others have taken Arrow’s work and extended its logic to incentives driving strong companies to acquire those firms viewed as economically weaker but with novel products. If we look at the efficiency effect we can see its relevance in pharma M&A. Specifically, the efficiency effect relates to the belief that the potential loss in revenues/profits can only be offset by either added R&D costs, with their incumbent greater element of risk, or the acquisition of a firm holding patent/s that are highly correlated to successful product development; thereby reducing risk. If we add to this the point that new products must be produced, marketed and sold, and we recognize this required expertise is costly for the new entrant to imitate, the new entrant’s desire to be bought aligns with the stronger firm's need to acquire. Obviously, it then comes down to a negotiated deal.
I would say to the board, if we read between the lines in the narrative, we can also surmise the greater logic why Elite should be acquired by a large pharma long before they would qualify for the Nasdaq.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM